Assertio Holdings is a specialized commercial pharmaceutical enterprise focused on acquiring, developing, and commercializing differentiated prescription products. The company leverages an innovative, commercial digital promotion model alongside traditional sales teams to market a diverse portfolio of pharmaceutical brands spanning neurology, pain management, and oncology, striving to maximize asset value and deliver therapeutic solutions to patients and healthcare providers.